Developing a lifetime disease model from RCT data using parametric models with time-updated covariates

von Schlackow, Iryna, Mihaylova, Borislava
Veröffentlicht 2013

Quality of care for secondary cardiovascular disease prevention in 2009–2017: population-wide cohort study of antiplatelet therapy use in Scotland

von Thalmann, Inna, Preiss, David, Schlackow, Iryna, Gray, Alastair, Mihaylova, Borislava
Veröffentlicht in BMJ Qual Saf (2023)

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

von Schlackow, Iryna, Kent, Seamus, Herrington, William, Emberson, Jonathan, Haynes, Richard, Reith, Christina, Collins, Rory, Landray, Martin J., Gray, Alastair, Baigent, Colin, Mihaylova, Borislava
Veröffentlicht in Kidney Int (2019)

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD

von Morton, Rachael L., Schlackow, Iryna, Staplin, Natalie, Gray, Alastair, Cass, Alan, Haynes, Richard, Emberson, Jonathan, Herrington, William, Landray, Martin J., Baigent, Colin, Mihaylova, Borislava
Veröffentlicht in Am J Kidney Dis (2016)

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease

von Schlackow, Iryna, Kent, Seamus, Herrington, William, Emberson, Jonathan, Haynes, Richard, Reith, Christina, Wanner, Christoph, Fellström, Bengt, Gray, Alastair, Landray, Martin J, Baigent, Colin, Mihaylova, Borislava
Veröffentlicht in Heart (2017)

Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data

von Schlackow, Iryna, Simons, Claire, Oke, Jason, Feakins, Benjamin, O’Callaghan, Christopher A., Hobbs, F. D Richard, Lasserson, Daniel, Stevens, Richard J., Perera, Rafael, Mihaylova, Borislava
Veröffentlicht in PLoS Med (2020)

What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?

von Kent, Seamus, Schlackow, Iryna, Lozano-Kühne, Jingky, Reith, Christina, Emberson, Jonathan, Haynes, Richard, Gray, Alastair, Cass, Alan, Baigent, Colin, Landray, Martin J, Herrington, William, Mihaylova, Borislava
Veröffentlicht in BMC Nephrol (2015)

Impact of CKD on Household Income

von Morton, Rachael L., Schlackow, Iryna, Gray, Alastair, Emberson, Jonathan, Herrington, William, Staplin, Natalie, Reith, Christina, Howard, Kirsten, Landray, Martin J., Cass, Alan, Baigent, Colin, Mihaylova, Borislava
Veröffentlicht in Kidney Int Rep (2017)

Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification

von Wyllie, David H, Walker, A Sarah, Miller, Ruth, Moore, Catrin, Williamson, Susan R, Schlackow, Iryna, Finney, John M, O'Connor, Lily, Peto, Tim E A, Crook, Derrick W
Veröffentlicht 2011

Surveillance of Infection Severity: A Registry Study of Laboratory Diagnosed Clostridium difficile

von Schlackow, Iryna, Walker, A. Sarah, Dingle, Kate, Griffiths, David, Oakley, Sarah, Finney, John, Vaughan, Ali, Gill, Martin J., Crook, Derrick W., Peto, Tim E. A., Wyllie, David H.
Veröffentlicht 2012

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)

von Mihaylova, Borislava, Schlackow, Iryna, Herrington, William, Lozano-Kühne, Jingky, Kent, Seamus, Emberson, Jonathan, Reith, Christina, Haynes, Richard, Cass, Alan, Craig, Jonathan, Gray, Alastair, Collins, Rory, Landray, Martin J., Baigent, Colin
Veröffentlicht in Am J Kidney Dis (2016)

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood

von Kent, Seamus, Becker, Frauke, Feenstra, Talitha, Tran-Duy, An, Schlackow, Iryna, Tew, Michelle, Zhang, Ping, Ye, Wen, Lizheng, Shi, Herman, William, McEwan, Phil, Schramm, Wendelin, Gray, Alastair, Leal, Jose, Lamotte, Mark, Willis, Michael, Palmer, Andrew J, Clarke, Philip
Veröffentlicht in Pharmacoeconomics (2019)